Data sharing: not as simple as it seems

被引:0
作者
Neil Pearce
Allan H Smith
机构
[1] London School of Hygiene and Tropical Medicine,Faculty of Epidemiology and Population Health
[2] Massey University Wellington Campus,Centre for Public Health Research
[3] University of California,Division of Epidemiology, School of Public Health
来源
Environmental Health | / 10卷
关键词
epidemiology; ethics; data sharing;
D O I
暂无
中图分类号
学科分类号
摘要
In recent years there has been a major change on the part of funders, particularly in North America, so that data sharing is now considered to be the norm rather than the exception. We believe that data sharing is a good idea. However, we also believe that it is inappropriate to prescribe exactly when or how researchers should preserve and share data, since these issues are highly specific to each study, the nature of the data collected, who is requesting it, and what they intend to do with it. The level of ethical concern will vary according to the nature of the information, and the way in which it is collected - analyses of anonymised hospital admission records may carry a quite different ethical burden than analyses of potentially identifiable health information collected directly from the study participants. It is striking that most discussions about data sharing focus almost exclusively on issues of ownership (by the researchers or the funders) and efficiency (on the part of the funders). There is usually little discussion of the ethical issues involved in data sharing, and its implications for the study participants. Obtaining prior informed consent from the participants does not solve this problem, unless the informed consent process makes it completely clear what is being proposed, in which case most study participants would not agree. Thus, the undoubted benefits of data sharing does not remove the obligations and responsibilities that the original investigators hold for the people they invited to participate in the study.
引用
收藏
相关论文
共 98 条
[1]  
Pearce N(1998)Epidemiologic studies of beta agonists and asthma deaths Epidemiologic Reviews 20 173-186
[2]  
Hensley MJ(2009)The use of beta agonists and the risk of death and near death from asthma Journal of Clinical Epidemiology 62 582-587
[3]  
Pearce N(1989)Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study.[comment] Lancet 1 917-922
[4]  
Crane J(1991)Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study.[comment] Thorax 46 105-111
[5]  
Pearce N(1990)Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81 Thorax 45 170-175
[6]  
Flatt A(2010)Does screening history explain the ethnic differences in stage at diagnosis of cervical cancer in New Zealand? International Journal of Epidemiology 39 156-165
[7]  
Burgess C(2009)Demographic Differences in Stage at Diagnosis and Cervical Cancer Survival in New Zealand, 1994-2005 Journal of Womens Health 18 955-963
[8]  
Jackson R(2011)Public good, personal privacy: a citizens' deliberation about using medical information for pharmacoepidemiological research Journal of Epidemiology and Community Health 65 150-156
[9]  
Kwong T(2011)Sharing Confidential Data for Research Purposes A Primer Epidemiology 22 632-635
[10]  
Ball M(2011)Linkage of census with mortality and cancer data in New Zealand Journal of Epidemiology and Community Health 65 A33-A33